首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Abdullah Al-Khanaty,David Hennes,Michael S Hofman et al. Abdullah Al-Khanaty et al.
The role of prostate biopsy in early detection is increasingly being questioned in the era of advanced imaging. With the widespread adoption of multiparametric magnetic resonance imaging and the emergence of prostate-specific membrane antig...
Mengyun Wang,Jianchuan Chen,Cheng Wang et al. Mengyun Wang et al.
Recent advances in liquid biopsy have highlighted the potential of urinary tumor DNA (utDNA) and exosomes as non-invasive biomarkers for diagnosis, molecular classification, staging, and therapeutic monitoring. utDNA reflects the genomic and epigenetic alterations of BC with high concordance to tumor...Future research integrating multi-omics profiling and artificial intelligence is expected to establish urinary liquid biopsy as a key tool for precision medicine in BC management.
Judith Büntzel,Markus Maulhardt,Alexander Casimir Angleitner et al. Judith Büntzel et al.
Conclusion: Flow-cytometric profiling of circulating large EV provides a feasible liquid biopsy approach for tumor characterization in HNSCC.
W L Zhong,H R Zheng,T X Lin W L Zhong
By analyzing tumor-derived cells and molecular information in urine or blood, liquid biopsy provides an important complementary approach for precision management of bladder cancer across the disease course....Owing to the direct contact between bladder tumors and urine, urine-based liquid biopsy is more suitable for screening, adjunctive diagnosis, and intravesical recurrence monitoring....In contrast, blood-based liquid biopsy better reflects systemic tumor biology and has potential value in perioperative adjuvant treatment decision-making and treatment response monitoring....Nevertheless, the clinical translation of liquid biopsy still faces challenges, including insufficient sample standardization, heterogeneous detection systems, and relatively high costs.
R Muhtadi,N Schmid,D Bernhardt et al. R Muhtadi et al.
Our findings may point to the possible utility of gene expression measurements in peripheral whole blood as a simplified liquid biopsy method for GBM tumor recurrence.
Sara Atiq,Nikola A Bowden,Kristina Warton et al. Sara Atiq et al.
While there are no biomarkers that have been approved for population-wide screening, evidence strongly supports DNA methylation-based liquid biopsy approaches for screening and early detection of high-grade serous tubo-ovarian cancer.
Zhaocheng Liu,Rui Zhang,Chunyan Chang et al. Zhaocheng Liu et al.
By combining ultrahigh sensitivity, PAM independence, multiplexing preamplification capability, and practical affordability, DHCC provides an accessible platform for ctDNA-based liquid biopsy in clinical settings.
Abdul Rehman,Muhammad Awais,Hafiza Noor Ul Ain Baloch et al. Abdul Rehman et al.
Background/Objectives: Liquid biopsy (LB) is transforming cancer care by enabling minimally invasive tumor profiling. While current research and clinical pathways mostly focus on blood LB, sputum represents a non-invasive, readily available...
Chen Liu,Yanhao Chen,Xiang Li et al. Chen Liu et al.
Background: Lupus nephritis (LN) significantly contributes to morbidity and mortality in systemic lupus erythematosus (SLE) patients. Although renal biopsy is the diagnostic "gold standard," its invasiveness limits ongoin...
Sima Singh,Ada Raucci,Antonella Miglione et al. Sima Singh et al.
Unlike tissue biopsy, which captures only a single tumor region at one moment, liquid biopsy enables repeated, minimally invasive sampling that reflects the molecular state of disease across all lesions.
耗时 0.15116 秒,为您在 49908165 条记录里面共找到 7187 篇文章 [XML]